Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | potassium voltage gated channel subfamily A | 0.0277 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0277 | 1 | 1 |
Echinococcus granulosus | potassium voltage gated channel protein | 0.0277 | 1 | 1 |
Leishmania major | ion transport protein-like protein | 0.0223 | 0.6565 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0277 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0277 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0132 | 0.0851 | 0.0851 |
Trypanosoma cruzi | ion transport protein, putative | 0.0223 | 0.6565 | 0.5 |
Trypanosoma cruzi | ion transport protein, putative | 0.0223 | 0.6565 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0263 | 0.9106 | 0.9106 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0263 | 0.9106 | 0.4744 |
Echinococcus multilocularis | potassium voltage gated channel subfamily A | 0.0265 | 0.9238 | 0.1475 |
Echinococcus multilocularis | potassium voltage gated channel protein | 0.0277 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0263 | 0.9106 | 0.4744 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.